HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer

被引：0
|
作者：
Agoston, P
Major, T
Somogyi, A
Baricza, K
Szasz, K
Lövey, J
Németh, G
Kasler, M
Fodor, J
机构：
[1] Natl Inst Oncol, Dept Radiotherapy, Budapest, Hungary
[2] Natl Inst Oncol, Dept Anaesthesiol & Intens Care, Budapest, Hungary
[3] Natl Inst Oncol, Dept Oncoplast Surg, Budapest, Hungary
来源：
RADIOTHERAPY AND ONCOLOGY | 2005年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [1] Ultrafractionated radiotherapy(RT) in localised prostate cancer:HDR brachytherapy vs stereotactic RT
    Tsang, Y. M.
    Tharmalingam, H.
    Belessiotis-Richards, K.
    Armstrong, S.
    Ostler, P.
    Hughes, R.
    Alonzi, R.
    Hoskin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S27 - S28
  • [2] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [3] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Aleksandra Kazi
    Guy Godwin
    John Simpson
    Giuseppe Sasso
    [J]. BMC Cancer, 10
  • [4] MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer
    Kazi, Aleksandra
    Godwin, Guy
    Simpson, John
    Sasso, Giuseppe
    [J]. BMC CANCER, 2010, 10
  • [5] Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre
    Lorimer, C.
    Ravi, B.
    Cowtan, F.
    Johns, A.
    Robinson, A.
    Nikapota, A.
    [J]. CLINICAL ONCOLOGY, 2023, 35 (02) : E241 - E241
  • [6] A prospective randomised trial of HDR brachytherapy boost in radical radiotherapy for localised carcinoma of the prostate
    Hoskin, P.
    Ostler, P.
    Bownes, P.
    Woodruffe, M.
    Philips, H.
    Motohashi, K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S148 - S148
  • [7] Stereotactic Body Radiotherapy (SBRT) Boost to Mimic High-Dose Rate (HDR) Brachytherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Study
    Al-Hanaqta, M.
    Loblaw, D. A.
    Chu, W.
    Ravi, A.
    Chiang, A. S., Jr.
    Jain, S.
    Chung, H. T.
    Vesprini, D.
    Morton, G.
    Deabreu, A.
    Mamedov, A.
    Zhang, L.
    Erler, D.
    Cheung, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S208 - S208
  • [8] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [9] HDR BRACHYTHERAPY OF PROSTATE CANCER AS A BOOST AFTER EXTERNAL BEAM RADIOTHERAPY
    Kanikowski, M.
    Skowronek, J.
    Kubaszewska, M.
    Chichel, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S324 - S324
  • [10] Salvage HDR brachytherapy for localised recurrent prostate cancer after primary irradiation
    Stankiewicz, M.
    Wojcieszek, P.
    Lelek, P.
    Krzysztofiak, T.
    Kellas-Sleczka, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1096 - S1097
12345